P. Astoul (Marseille Cedex 09, France), G. Tassi (Gussago (Bs), Italy)
Diagnostic usefulness of tumour markers in pleural effusions
L. Antonangelo, A. Cora, M. Acencio, S. Dias, L. Teixeira, R. Sales, F. Vargas (Sao Paulo, Brazil)
|   |
Soluble mesothelin as an early diagnostic tool in asbestos-exposed workers
K. Hollevoet, J. Van Cleemput, J. Thimpont, M. Vandeweerdt, P. De Vuyst, K. Nackaerts, J. Delanghe, C. Legrand, J. P. van Meerbeeck (Ghent, Kapelle-op-den-Bos, Brussels, Leuven, Louvain-la-Neuve, Belgium)
| |
Glomerular filtration rate is a confounder for determination of serum soluble mesothelin
K. Hollevoet, D. Bernard, F. De Geeter, N. Walgraeve, A. Van den Eeckhaut, R. Vanholder, C. Van de Wiele, V. Stove, J. P. van Meerbeeck, J. R. Delanghe (Ghent, Bruges, Belgium)
| |
The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions
P. Kapisyzi, D. Argjiri, G. Byrazeri, J. Beli, Y. Vakeflliu, R. Kore, E. Shehu, A. Aliko, A. Mitre (Tirana, Tirane, Albania)
| |
Rapid evaluation of exudative pleural effusion using C-reactive protein
M. E. Cioroiu, R. Cernat, L. Balta, L. Butnaru (Iasi, Romania)
| |
Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
J. Lalic, I. Djordjevic, T. Pejcic, I. Stankovic, V. Veljovic (Nis, Republic Of Serbia)
| |
Procalcitonin and CRP levels in pleural effusions
L. Pisani, A. Ricci, P. Bruno, A. Pezzuto, F. Fioretti, M. L. Troccoli, S. Mariotta (Rome, Italy)
| |
Diagnostic value of procalcitonin and C-reactive protein in the differentiation among bening and malignant pleural effusion
M. Botana Rial, P. Casado Rey, M. A. Andrade Olivié, A. Fernández-Villar, V. Leiro Fernández, C. Represas Represas, A. Pallarés Sanmartín, A. Cobas Paz (Vigo, Spain)
| |
The value of IL6 in differentiation between malignant and non malignant pleural effusion
H.H. Masoud, R. Emam, M. Gabr (Cairo, Egypt)
| |
Does pleural fluid sample size matter in the cytopathological assessment of unilateral pleural effusion?
J. Evans, M. Lapsley, N. Cooke, S. Paramothayan, V. Varney (London, United Kingdom)
| |
Parapneumonic pleural effusion (ppnpe) and microbiological isolation. Study routine or selective?
M. Alonso Plasencia, E. Perez Rodriguez, A. Hernando Sanz, R. Gomez Garcia, D. Kopecna, C. Zamarro Garcia, C. Wagner Struwing, D. Sanchez Mellado, A. Sam Cerna, S. Diaz Lobato (Madrid, Spain)
| |
Proportion of patients with malignant pleural mesothelioma whose asbestos body numbers in the lung are equal to general population
K. Okabe, E. Matsuda, H. Tao, S. Kobayashi, K. Sugi, M. Katler, J. Godleski (Ube, Japan; Boston, United States Of America)
| |
Malignant pleural effusions (MPE) – comparative yield of cytological and histopathological methods
M. Fijalkowski, A. Rul (Lodz, Poland)
| |
An audit of the use of Abrams‘ pleural biopsy in the diagnosis of mesothelioma
J. S. Khangura, A. Snow, M. Desmond (Salisbury, Isle of Wight, United Kingdom)
| |
Correlation between computed tomography (CT) and thoracoscopic biopsy in pleural disease
M. Griffin, R. Naseer, S. Kearney, M. Munavvar (Preston, Manchester, United Kingdom)
| |
Predictors of trapped lung in patients with malignant pleural effusions; comparison of pleural elastance and pleural fluid pH
H. Yildirim, M. Metintas, G. Ak, S. Erginel, F. Alatas (Eskisehir, Turkey)
| |
Thymic neuroendocrine tumours: experience at the institut Gustave Roussy
A. Bonnichon, J. Guigay, E. Baudin, P. Duvillard, P. Ruffie, J. Margery (Villejuif, Clamart, France)
| |
Paraganglioma of the mediastinum – 18 years experience
D. Jovanovic, S. Popevic, R. Stevic, N. Vasic, M. Velinovic, N. Samard¿ic, V. Škodric (Belgrade, Republic Of Serbia)
| |